- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.27 | 1.91 |
NAV | ₹31.81 | ₹39.75 |
Fund Started | 20 Jun 2019 | 25 Jun 2018 |
Fund Size | ₹890.33 Cr | ₹5320.29 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.27
1.91
NAV
₹31.81
₹39.75
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹890.33 Cr
₹5320.29 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 31.77% | 43.24% |
3 Year | 18.31% | 24.47% |
5 Year | 24.36% | 30.79% |
1 Year
31.77%
43.24%
3 Year
18.31%
24.47%
5 Year
24.36%
30.79%
Holding Analysis
Equity | 97.82% | 97.27% |
Cash | 2.18% | 2.73% |
Equity
97.82%
97.27%
Cash
2.18%
2.73%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.31% |
Cipla Ltd. | 9.01% |
Torrent Pharmaceuticals Ltd. | 8.35% |
Apollo Hospitals Enterprise Ltd. | 5.91% |
Fortis Healthcare Ltd. | 5.61% |
Aurobindo Pharma Ltd. | 5.04% |
Lupin Ltd. | 4.71% |
Ajanta Pharma Ltd. | 4.58% |
Ipca Laboratories Ltd. | 3.98% |
Alkem Laboratories Ltd. | 3.29% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.77% |
Dr. Reddy's Laboratories Ltd. | 8.48% |
Cipla Ltd. | 7.94% |
Aurobindo Pharma Ltd. | 5.04% |
Gland Pharma Ltd. | 4.38% |
Lupin Ltd. | 4.29% |
Alkem Laboratories Ltd. | 4.16% |
Zydus Lifesciences Ltd. | 3.10% |
Apollo Hospitals Enterprise Ltd. | 2.93% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Dhaval Joshi | Dharmesh Kakkad |
Start Date | 21 Nov 2022 | 23 Feb 2021 |
Name
Dhaval Joshi
Dharmesh Kakkad
Start Date
21 Nov 2022
23 Feb 2021
About Fund
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 20 Jun 2019 | 25 Jun 2018 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018
